Healthy men help measure drug absorption in tiny radioactive trial
NCT ID NCT07301723
First seen Jan 06, 2026 · Last updated May 12, 2026 · Updated 16 times
Summary
This completed Phase 1 trial enrolled 6 healthy men to find out how much of the drug cenerimod enters the bloodstream after taking a pill. Participants took one tablet, then received a tiny radioactive version of the drug through an IV to track it. The study lasted about 3 months and focused on drug absorption and safety, not treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pharmaceutical Research Associates Group B.V.
Groningen, 9728, Netherlands
Conditions
Explore the condition pages connected to this study.